课题基金 / 基金详情

Hypertension and regulation of angiotensinogen gene expression in transgenic mice

Hypertension and regulation of angiotensinogen gene expression in transgenic mice
转基因小鼠的高血压与血管紧张素原基因表达的调节
批准号：
171137
负责人：
Chan John S
金额：
$22.2万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2011-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=171137&lang=en
关键词：
Angiotensinogen Gene Diabetes Heterogenous Ribonucleoprotein F Hypertension Kidney Transgenic Mice

项目摘要

项目成果

Chan John S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hypertension is a medical condition in which the blood pressure is chronically elevated. Persistent hypertension is one of the risk factors for vascular diseases, strokes, heart attacks, heart and kidney failure. Hypertension is invariably associated with
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in the Progression of Diabetic Nephropathy: Friend or foe?
海外基金